MATERIAL EVENT4896.TTSE

K Pharma: change of independent auditor

Summary

K Pharma, Inc. filed an extraordinary report via EDINET on 2026-02-20 16:00 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100XMJ7 ↗ · PDL1.0 · Not investment advice